BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Puderbach M, Eichinger M. The role of advanced imaging techniques in cystic fibrosis follow-up: is there a place for MRI? Pediatr Radiol 2010;40:844-9. [PMID: 20432002 DOI: 10.1007/s00247-010-1589-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Amaxopoulou C, Gnannt R, Higashigaito K, Jung A, Kellenberger CJ. Structural and perfusion magnetic resonance imaging of the lung in cystic fibrosis. Pediatr Radiol 2018;48:165-75. [PMID: 29143200 DOI: 10.1007/s00247-017-4021-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
2 Dournes G, Grodzki D, Macey J, Girodet PO, Fayon M, Chateil JF, Montaudon M, Berger P, Laurent F. Quiet Submillimeter MR Imaging of the Lung Is Feasible with a PETRA Sequence at 1.5 T. Radiology 2015;276:258-65. [PMID: 25768672 DOI: 10.1148/radiol.15141655] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 11.9] [Reference Citation Analysis]
3 Tiddens HAWM, Puderbach M, Venegas JG, Ratjen F, Donaldson SH, Davis SD, Rowe SM, Sagel SD, Higgins M, Waltz DA. Novel outcome measures for clinical trials in cystic fibrosis. Pediatr Pulmonol 2015;50:302-15. [PMID: 25641878 DOI: 10.1002/ppul.23146] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
4 Simpson SJ, Mott LS, Esther CR Jr, Stick SM, Hall GL. Novel end points for clinical trials in young children with cystic fibrosis. Expert Rev Respir Med 2013;7:231-43. [PMID: 23734646 DOI: 10.1586/ers.13.25] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
5 Mordacq C, Deschildre A, Petyt L, Santangelo T, Delvart C, Doan C, Thumerelle C. [Chest computed tomography in children: indications, efficiency and effective dose]. Arch Pediatr 2014;21:279-86. [PMID: 24485863 DOI: 10.1016/j.arcped.2013.12.021] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Bajd F, Serša I. A Bond-Fluctuation Model of Translational Dynamics of Chain-like Particles through Mucosal Scaffolds. Biophys J 2018;114:2732-42. [PMID: 29874621 DOI: 10.1016/j.bpj.2018.04.031] [Reference Citation Analysis]
7 Eslamy HK, Newman B. Pneumonia in normal and immunocompromised children: an overview and update. Radiol Clin North Am 2011;49:895-920. [PMID: 21889014 DOI: 10.1016/j.rcl.2011.06.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 2.1] [Reference Citation Analysis]
8 Montella S, Maglione M, Bruzzese D, Mollica C, Pignata C, Aloj G, Manna A, Esposito A, Mirra V, Santamaria F. Magnetic resonance imaging is an accurate and reliable method to evaluate non-cystic fibrosis paediatric lung disease: Accuracy of MRI in chronic lung disease. Respirology 2012;17:87-91. [DOI: 10.1111/j.1440-1843.2011.02067.x] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 4.5] [Reference Citation Analysis]
9 Ferris H, Twomey M, Moloney F, O’Neill SB, Murphy K, O’Connor OJ, Maher M. Computed tomography dose optimisation in cystic fibrosis: A review. World J Radiol 2016; 8(4): 331-341 [PMID: 27158420 DOI: 10.4329/wjr.v8.i4.331] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Sun Y, O'Sullivan BP, Roche JP, Walvick R, Reno A, Baker D, Mansour JK, Albert MS. Using hyperpolarized 3He MRI to evaluate treatment efficacy in cystic fibrosis patients. J Magn Reson Imaging 2011;34:1206-11. [PMID: 21932361 DOI: 10.1002/jmri.22724] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
11 Delacoste J, Feliciano H, Yerly J, Dunet V, Beigelman‐aubry C, Ginami G, van Heeswijk RB, Piccini D, Stuber M, Sauty A. A black‐blood ultra‐short echo time (UTE) sequence for 3D isotropic resolution imaging of the lungs. Magn Reson Med 2019;81:3808-18. [DOI: 10.1002/mrm.27679] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
12 Westra SJ. The communication of the radiation risk from CT in relation to its clinical benefit in the era of personalized medicine: part 2: benefits versus risk of CT. Pediatr Radiol 2014;44 Suppl 3:525-33. [PMID: 25304716 DOI: 10.1007/s00247-014-3087-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
13 Folescu TW, Marques Ede A, Boechat MC, Daltro P, Higa LY, Cohen RW. High-resolution computed tomography scores in cystic fibrosis patients colonized with Pseudomonas aeruginosa or Staphylococcus aureus. J Bras Pneumol 2012;38:41-9. [PMID: 22407039 DOI: 10.1590/s1806-37132012000100007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
14 Meltzer C, Båth M, Kheddache S, Ásgeirsdóttir H, Gilljam M, Johnsson ÅA. VISIBILITY OF STRUCTURES OF RELEVANCE FOR PATIENTS WITH CYSTIC FIBROSIS IN CHEST TOMOSYNTHESIS: INFLUENCE OF ANATOMICAL LOCATION AND OBSERVER EXPERIENCE. Radiat Prot Dosimetry 2016;169:177-87. [PMID: 26842827 DOI: 10.1093/rpd/ncv556] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
15 Sheahan KP, Glynn D, Joyce S, Maher MM, Boland F, O'Connor OJ. Best Practices: Imaging Strategies for Reduced-Dose Chest CT in the Management of Cystic Fibrosis-Related Lung Disease. AJR Am J Roentgenol 2021;217:304-13. [PMID: 34076456 DOI: 10.2214/AJR.19.22694] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Tepper LA, Ciet P, Caudri D, Quittner AL, Utens EM, Tiddens HA. Validating chest MRI to detect and monitor cystic fibrosis lung disease in a pediatric cohort: Cystic Fibrosis Lung Disease in a Pediatric Cohort. Pediatr Pulmonol 2016;51:34-41. [DOI: 10.1002/ppul.23328] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
17 Murphy KP, Maher MM, O'Connor OJ. Imaging of Cystic Fibrosis and Pediatric Bronchiectasis. AJR Am J Roentgenol 2016;206:448-54. [PMID: 26901001 DOI: 10.2214/AJR.15.14437] [Cited by in Crossref: 14] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
18 Szczesniak R, Turkovic L, Andrinopoulou ER, Tiddens HAWM. Chest imaging in cystic fibrosis studies: What counts, and can be counted? J Cyst Fibros 2017;16:175-85. [PMID: 28040479 DOI: 10.1016/j.jcf.2016.12.008] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 6.0] [Reference Citation Analysis]
19 Sileo C, Corvol H, Boelle PY, Blondiaux E, Clement A, Ducou Le Pointe H. HRCT and MRI of the lung in children with cystic fibrosis: comparison of different scoring systems. J Cyst Fibros 2014;13:198-204. [PMID: 24095209 DOI: 10.1016/j.jcf.2013.09.003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 3.8] [Reference Citation Analysis]